Norepinephrine Bitartrate Injection
Product Images NDC 0143-9318

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 0143-9318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Norepinephrine Bitartrate Injection Usp 1)

Chemical structure diagram showing the molecular components of norepinephrine bitartrate, including the norepinephrine molecule linked to the bitartrate moiety with water of crystallization indicated.*

FDA Label Image

Plb191 (Norepinephrine Bitartrate Injection Usp 2)

Label for Norepinephrine Bitartrate Injection, USP, 4 mg per 4 mL (1 mg/mL) single dose vial. The intravenous injection is indicated for infusion only. Manufactured by Hikma Farmacêutica (Portugal), distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Shelfpack June 2018 2 (Norepinephrine Bitartrate Injection Usp 3)

Norepinephrine Bitartrate Injection, USP in a 4 mg per 4 mL (1 mg/mL) strength vial label by Hikma Pharmaceuticals USA Inc. The label indicates single dose vials (10 x 4 mL) for intravenous use. It includes usage warnings, storage instructions at 20° to 25°C, and a note that the product contains sulfites.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.